Company news

Xeris Biopharma Holdings, Inc. news in 2025

Xeris Biopharma Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application

November 30, 2025

Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025

November 5, 2025

Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

October 22, 2025

Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®

August 24, 2025

Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance

August 6, 2025

Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025

July 30, 2025

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

June 2, 2025

Xeris Announces Details for Analyst & Investor Day

May 19, 2025

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

May 8, 2025

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

April 30, 2025

Xeris Announces Changes to Its Board of Directors

March 27, 2025

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

March 16, 2025

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

March 5, 2025

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

February 26, 2025

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

February 23, 2025

Xeris to Participate in Upcoming Investor Conferences

February 4, 2025

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

January 20, 2025

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

January 9, 2025

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

January 5, 2025

Calls in 2025

Decks in 2025